Literature DB >> 10036588

Autonomic dysfunction in familial amyloidotic polyneuropathy (FAP).

Y Ando1, O B Suhr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10036588     DOI： 10.3109/13506129809007303

Source DB:  PubMed          Journal:  Amyloid        ISSN： 1350-6129            Impact factor:   7.141


× No keyword cloud information.
  16 in total

1.  Widespread cardiovascular autonomic dysfunction in primary amyloidosis: does spontaneous hyperventilation have a compensatory role against postural hypotension?

Authors:  L Bernardi; C Passino; C Porta; E Anesi; G Palladini; G Merlini
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

2.  Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.

Authors:  Christine E Bulawa; Stephen Connelly; Michael Devit; Lan Wang; Charlotte Weigel; James A Fleming; Jeff Packman; Evan T Powers; R Luke Wiseman; Theodore R Foss; Ian A Wilson; Jeffery W Kelly; Richard Labaudinière
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

3.  Transthyretin-related familial amyloid polyneuropathy: evaluation of CSF enhancement on serial T1-weighted and fluid-attenuated inversion recovery images following intravenous contrast administration.

Authors:  Toshinori Hirai; Yukio Ando; Masayuki Yamura; Mika Kitajima; Yoshiko Hayashida; Yukunori Korogi; Taro Yamashita; Yasuyuki Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

Review 4.  Current and future treatment of amyloid diseases.

Authors:  M Ankarcrona; B Winblad; C Monteiro; C Fearns; E T Powers; J Johansson; G T Westermark; J Presto; B-G Ericzon; J W Kelly
Journal:  J Intern Med       Date:  2016-05-10       Impact factor: 8.989

Review 5.  The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug.

Authors:  Steven M Johnson; Stephen Connelly; Colleen Fearns; Evan T Powers; Jeffery W Kelly
Journal:  J Mol Biol       Date:  2012-01-05       Impact factor: 5.469

Review 6.  Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis).

Authors:  Alejandra Gonzalez-Duarte
Journal:  Clin Auton Res       Date:  2018-03-06       Impact factor: 4.435

Review 7.  Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP).

Authors:  Yukio Ando
Journal:  Med Mol Morphol       Date:  2005-09       Impact factor: 2.309

8.  Circadian rhythm of protein C in human plasma--useful marker of autonomic function in liver.

Authors:  Konen Obayashi; Osamu Hanyu; Takashi Miida; Yukio Ando; Masaaki Nakamura; Ying Zhu; Masahiko Okada
Journal:  Clin Auton Res       Date:  2005-02       Impact factor: 4.435

9.  Patterns of neuropathy and autonomic failure in patients with amyloidosis.

Authors:  Annabel K Wang; Robert D Fealey; Tonette L Gehrking; Phillip A Low
Journal:  Mayo Clin Proc       Date:  2008-11       Impact factor: 7.616

10.  AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.

Authors:  Sravan C Penchala; Stephen Connelly; Yu Wang; Miki S Park; Lei Zhao; Aleksandra Baranczak; Irit Rappley; Hannes Vogel; Michaela Liedtke; Ronald M Witteles; Evan T Powers; Natàlia Reixach; William K Chan; Ian A Wilson; Jeffery W Kelly; Isabella A Graef; Mamoun M Alhamadsheh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.